JPWO2022202785A1 - - Google Patents

Info

Publication number
JPWO2022202785A1
JPWO2022202785A1 JP2023509184A JP2023509184A JPWO2022202785A1 JP WO2022202785 A1 JPWO2022202785 A1 JP WO2022202785A1 JP 2023509184 A JP2023509184 A JP 2023509184A JP 2023509184 A JP2023509184 A JP 2023509184A JP WO2022202785 A1 JPWO2022202785 A1 JP WO2022202785A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023509184A
Other languages
Japanese (ja)
Other versions
JPWO2022202785A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022202785A1 publication Critical patent/JPWO2022202785A1/ja
Publication of JPWO2022202785A5 publication Critical patent/JPWO2022202785A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023509184A 2021-03-22 2022-03-22 Pending JPWO2022202785A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021047225 2021-03-22
PCT/JP2022/013074 WO2022202785A1 (ja) 2021-03-22 2022-03-22 ポリペプチド並びにそれを含む細胞融合剤及びがん治療用医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2022202785A1 true JPWO2022202785A1 (https=) 2022-09-29
JPWO2022202785A5 JPWO2022202785A5 (https=) 2024-12-16

Family

ID=83397484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509184A Pending JPWO2022202785A1 (https=) 2021-03-22 2022-03-22

Country Status (3)

Country Link
US (1) US20250129122A1 (https=)
JP (1) JPWO2022202785A1 (https=)
WO (1) WO2022202785A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025225632A1 (ja) * 2024-04-23 2025-10-30 美智子 甲賀 コロナウイルス感染症の治療又は予防用医薬組成物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099862A1 (en) * 2002-05-24 2003-12-04 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
JP2008505854A (ja) * 2004-06-18 2008-02-28 イーペーエフ ファルマシューティカルス ゲゼルシャフト ミット ベシュレンクテル ハフツング オリゴマーペプチドおよびhiv感染症の治療のためのその使用
US20080145876A1 (en) * 2006-11-21 2008-06-19 University Of Southern California Poly(ethylene glycol) anti-body detection assays and kits for performing thereof
JP2008532549A (ja) * 2005-03-15 2008-08-21 アラーガン、インコーポレイテッド 内因性クロストリジウム毒素受容体系に対する増大した標的能力を有する修飾クロストリジウム毒素
WO2011063128A1 (en) * 2009-11-18 2011-05-26 Affinergy, Inc. Implantable bone graft materials
US20190284240A1 (en) * 2016-11-22 2019-09-19 Ohio State Innovation Foundation Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021054448A1 (ja) * 2019-09-20 2021-03-25 美智子 甲賀 ペプチド並びにそれを含む細胞融合剤及びがん治療用医薬組成物

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099862A1 (en) * 2002-05-24 2003-12-04 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
JP2008505854A (ja) * 2004-06-18 2008-02-28 イーペーエフ ファルマシューティカルス ゲゼルシャフト ミット ベシュレンクテル ハフツング オリゴマーペプチドおよびhiv感染症の治療のためのその使用
JP2008532549A (ja) * 2005-03-15 2008-08-21 アラーガン、インコーポレイテッド 内因性クロストリジウム毒素受容体系に対する増大した標的能力を有する修飾クロストリジウム毒素
US20080145876A1 (en) * 2006-11-21 2008-06-19 University Of Southern California Poly(ethylene glycol) anti-body detection assays and kits for performing thereof
WO2011063128A1 (en) * 2009-11-18 2011-05-26 Affinergy, Inc. Implantable bone graft materials
US20190284240A1 (en) * 2016-11-22 2019-09-19 Ohio State Innovation Foundation Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof

Also Published As

Publication number Publication date
WO2022202785A1 (ja) 2022-09-29
US20250129122A1 (en) 2025-04-24

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20230928

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251209

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260209